Over 1,700 Medicare prescription drugs and managed care plans have applied to participate in a Trump administration savings model that will mean seniors won’t have to pay more than $35 per month for insulin, the CMS announced Tuesday.
Nearly half of all eligible Medicare Part D and Medicare Advantage plans will offer this, President Donald Trump said Tuesday afternoon in the White House Rose Garden. Some plans may even choose to offer insulin at no cost, he added.
The Rose Garden event occurred as the president and his advisers sought to shore up his support among seniors. Trump’s internal polling ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.